Acceptability Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene

The purpose of this study is to demonstrate the safety of the gynaecological formulation in normal and usual usage condition.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hygiene

Age range

18 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

Sanofi-Aventis

São Paulo, Brazil

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Integral skin in the tested region

Exclusion criteria

Pregnancy or breastfeeding women
Use of antiinflammatory or immunosuppression drugs
Topical medication use at the tested region
Active cutaneous gynaecological disease
Personal history of allergic disease at the area to be treated
Allergic or atopic history

Treatment and study plan

lactoserum

Drug

Primary outcomes

Adverse Events and its association with the drug in study

Sponsors and collaborators

Lead sponsor

Sanofi

Industry

Registry information

Official study title

Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata New Fragrance

Important dates

Study start: 2006
First posted: Aug 30, 2006
Registry last updated: May 16, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed